Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Rheumatology International|March 3, 2025
ANCA-associated vasculitis and the impact of diffuse alveolar hemorrhage in elderly patients: a retrospective cohort studyMatthias Schaier, Florian Kälble, Louise Benning, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 3, 2013
The extent of HLA-DR expression on HLA-DR(+) Tregs allows the identification of patients with clinically relevant borderline rejectionMatthias Schaier, Nicole Seissler, Luis Eduardo Becker, et al.
Basic Research in Cardiology|March 17, 2009
Effect of insulin and glucose infusion on myocardial infarction size in uraemic ratsRalf Dikow, Caroline Wasserhess, Katrin Zimmerer, et al.
Clinical and Experimental Rheumatology|June 24, 2020
The onset of active disease in systemic lupus erythematosus patients is characterised by excessive regulatory CD4+-T-cell differentiationMatthias Schaier, Claudius Gottschalk, Florian Kälble, et al.
Arthritis Research & Therapy|December 20, 2018
Immunosuppressive therapy influences the accelerated age-dependent T-helper cell differentiation in systemic lupus erythematosus remission patientsMatthias Schaier, Claudius Gottschalk, Lorenz Uhlmann, et al.
Journal of Medical Virology|December 12, 2023
Live-virus serum neutralization after bivalent SARS-CoV-2 mRNA vaccination in hemodialysis patientsLouise Benning, Marie Bartenschlager, Heeyoung Kim, et al.
Immunology and Cell Biology|April 28, 2015
The role of recent thymic emigrant-regulatory T-cell (RTE-Treg) differentiation during pregnancyMiriam I Wagner, Charlotte Mai, Edgar Schmitt, et al.
Immunology|May 4, 2018
End-stage renal disease, dialysis, kidney transplantation and their impact on CD4<sup>+</sup> T-cell differentiationMatthias Schaier, Angele Leick, Lorenz Uhlmann, et al.
Vaccines|October 26, 2021
Longitudinal Humoral Responses after COVID-19 Vaccination in Peritoneal and Hemodialysis Patients over Twelve WeeksClaudius Speer, Matthias Schaier, Christian Nusshag, et al.
Plos One|March 28, 2019
First-in-human Phase I studies of PRS-080#22, a hepcidin antagonist, in healthy volunteers and patients with chronic kidney disease undergoing hemodialysisLutz Renders, Klemens Budde, Christian Rosenberger, et al.
Pageof 7